Home > Insider Trading > Filing (0001209191-18-005474)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1318568	Everi Holdings Inc.	EVRI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313332	D Michael Rumbolz	7250 S Tenaya Way #100 Las Vegas NV 89113	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-01-23	5,459	$5.77	110,302	No	4	M	Direct
Common Stock	Disposition	2018-01-23	5,459	$8.00	104,843	No	4	S	Direct
Common Stock	Acquisiton	2018-01-24	27,907	$5.77	132,750	No	4	M	Direct
Common Stock	Disposition	2018-01-24	27,907	$8.00	104,843	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-01-23	5,459	$0.00	5,459	$5.77
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-01-24	27,907	$0.00	27,907	$5.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
70,407		2018-08-25	No	4	M	Direct
42,500		2018-08-25	No	4	M	Direct

Footnotes

The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on December 12, 2017. The plan provides for a maximum number of options of 85,000 to be sold.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.02, inclusive. The reporting person undertakes to provide to the corporation, any security holder of the corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The options referenced on this Form 4 would have expired within the next twelve months and the remaining 42,500 options remain subject to expiration, unless they are exercised prior to the expiration date set forth above.
The options representing a right to purchase a total of 100,000 shares, became exercisable periodically over a period of four years beginning on the date of grant.